Derma Sciences, Inc. Introduces 2015 Financial Guidance And Provides 2014 Preliminary Net Sales

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, introduces financial guidance for the year ended December 31, 2015 and provides preliminary net sales for the year ended December 31, 2014. Derma Sciences expects 2015 net sales to be approximately $88.1 million, representing growth of 5% compared with preliminary 2014 net sales of $83.7 million. Net sales of advanced wound care (AWC) products are expected to be a record $43.8 million for the year, representing growth of 15% compared, with preliminary 2014 AWC net sales of $38.1 million. Net sales of traditional wound care (TWC) products are expected to be $44.3 million, representing a decline of 3% compared with preliminary 2014 TWC net sales of $45.6 million.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC